Alpha-9 Oncology

Alpha-9 Oncology is a clinical-stage biotechnology company focused on developing innovative radiopharmaceuticals for the treatment of various cancers, including both solid and hematologic malignancies. Their unique approach involves engineering bespoke radiopharmaceuticals designed to deliver radiation directly to tumor sites with minimal off-target effects, maximizing treatment efficacy while minimizing potential side effects. They are leveraging a robust pipeline of novel radiopharmaceuticals and a systematic approach to molecule design, which allows for efficient expansion into a multitude of validated oncology targets.

Alpha-9 Oncology boasts a team of experienced researchers and scientists with expertise in peptide chemistry, cancer imaging, and radiopharmaceutical development. The company is backed by top-tier investors and is well-positioned to expand its team and accelerate its pipeline. Their commitment to innovation and improving the lives of cancer patients has led them to secure strategic supply agreements with industry leaders in the radiopharmaceutical field, ensuring they have access to high-quality isotopes for their ongoing research and clinical trials.

Alpha-9 Oncology offers a comprehensive benefits package to its employees, including full extended health and dental coverage, a competitive salary, bonus, and equity, commuter reimbursement, a group registered retirement savings plan with a 5% employer match, 20 vacation days, 14 holidays, 5 sick days, long-term disability, life insurance, and the opportunity to contribute to impactful, rewarding work.

Alpha-9 Oncology is a clinical-stage biotechnology company dedicated to developing radiopharmaceuticals for the treatment of solid and hematologic malignancies. Their mission is to meaningfully improve the lives of cancer patients by engineering highly targeted radiopharmaceuticals that deliver radiation directly to tumor sites while minimizing off-target effects. Their approach uses proprietary technologies and deep foundational expertise to create bespoke molecules, optimized for selectivity, radiation delivery, and stability. Alpha-9's innovative pipeline of radiopharmaceuticals has the potential to provide more effective and tolerable treatment options for patients.

Alpha-9 Oncology promotes a culture of collaboration, transparency, and innovation, where driven, creative, and entrepreneurial individuals are encouraged to contribute to the company's mission of developing new medicines to help people living with cancer.

Alpha-9 Oncology is committed to fostering a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. The company is actively working to build a diverse team, ensuring equitable treatment for all, and creating an inclusive environment that embraces a variety of backgrounds, experiences, and ideas.